Literature DB >> 8651276

Differential effects of FGFR2 mutations on syndactyly and cleft palate in Apert syndrome.

S F Slaney1, M Oldridge, J A Hurst, G M Moriss-Kay, C M Hall, M D Poole, A O Wilkie.   

Abstract

Apert syndrome is a distinctive human malformation characterized by craniosynostosis and severe syndactyly of the hands and feet. It is caused by specific missense substitutions involving adjacent amino acids (Ser252Trp or Pro253Arg) in the linker between the second and third extracellular immunoglobulin domains of fibroblast growth factor receptor 2 (FGFR2). We have developed a simple PCR assay for these mutations in genomic DNA, based on the creation of novel (SfiI) and (BstUI) restriction sites. Analysis of DNA from 70 unrelated patients with Apert syndrome showed that 45 had the Ser252Trp mutation and 25 had the Pro253Arg mutation. Phenotypic differences between these two groups of patients were investigated. Significant differences were found for severity of syndactyly and presence of cleft palate. The syndactyly was more severe with the Pro253Arg mutation, for both the hands and the feet. In contrast, cleft palate was significantly more common in the Ser252Trp patients. No convincing differences were found in the prevalence of other malformations associated with Apert syndrome. We conclude that, although the phenotype attributable to the two mutations is very similar, there are subtle differences. The opposite trends for severity of syndactyly and cleft palate in relation to the two mutations may relate to the varying patterns of temporal and tissue-specific expression of different fibroblast growth factors, the ligands for FGFR2.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8651276      PMCID: PMC1914616     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  40 in total

1.  A procedure for in vitro amplification of DNA segments that lie outside the boundaries of known sequences.

Authors:  T Triglia; M G Peterson; D J Kemp
Journal:  Nucleic Acids Res       Date:  1988-08-25       Impact factor: 16.971

2.  Intellectual development in Apert's syndrome: a long term follow up of 29 patients.

Authors:  M A Patton; J Goodship; R Hayward; R Lansdown
Journal:  J Med Genet       Date:  1988-03       Impact factor: 6.318

3.  Male transmission of Apert syndrome.

Authors:  B R Rollnick
Journal:  Clin Genet       Date:  1988-02       Impact factor: 4.438

4.  Spontaneous mutation and parental age in humans.

Authors:  N Risch; E W Reich; M M Wishnick; J G McCarthy
Journal:  Am J Hum Genet       Date:  1987-08       Impact factor: 11.025

5.  A study of parental age effects on the occurrence of fresh mutations for the Apert syndrome.

Authors:  J D Erickson; M M Cohen
Journal:  Ann Hum Genet       Date:  1974-07       Impact factor: 1.670

6.  Genetics of common disorders.

Authors:  C O Carter
Journal:  Br Med Bull       Date:  1969-01       Impact factor: 4.291

Review 7.  The central nervous system in the Apert syndrome.

Authors:  M M Cohen; S Kreiborg
Journal:  Am J Med Genet       Date:  1990-01

Review 8.  Fibroblast-growth-factor receptor mutations in human skeletal disorders.

Authors:  M Muenke; U Schell
Journal:  Trends Genet       Date:  1995-08       Impact factor: 11.639

9.  Oculocutaneous albinism associated with Apert's syndrome.

Authors:  S Margolis; I M Siegel; A Choy; G M Breinin
Journal:  Am J Ophthalmol       Date:  1977-12       Impact factor: 5.258

10.  Novel FGFR2 mutations in Crouzon and Jackson-Weiss syndromes show allelic heterogeneity and phenotypic variability.

Authors:  W J Park; G A Meyers; X Li; C Theda; D Day; S J Orlow; M C Jones; E W Jabs
Journal:  Hum Mol Genet       Date:  1995-07       Impact factor: 6.150

View more
  57 in total

1.  Why study human limb malformations?

Authors:  Andrew O M Wilkie
Journal:  J Anat       Date:  2003-01       Impact factor: 2.610

Review 2.  Fibroblast growth factor receptor mutations and craniosynostosis: three receptors, five syndromes.

Authors:  A O Wilkie
Journal:  Indian J Pediatr       Date:  1996 May-Jun       Impact factor: 1.967

3.  The FGF and FGFR Gene Family and Risk of Cleft Lip With or Without Cleft Palate.

Authors:  Hong Wang; Tianxiao Zhang; Tao Wu; Jacqueline B Hetmanski; Ingo Ruczinski; Holger Schwender; Kung Yee Liang; Tanda Murray; M Daniele Fallin; Richard J Redett; Gerald V Raymond; Sheng-Chih Jin; Yah-Huei Wu Chou; Philip Kuo-Ting Chen; Vincent Yeow; Samuel S Chong; Felicia S H Cheah; Sun Ha Jee; Ethylin W Jabs; Alan F Scott; Terri H Beaty
Journal:  Cleft Palate Craniofac J       Date:  2011-11-10

4.  Impaired FGF signaling contributes to cleft lip and palate.

Authors:  Bridget M Riley; M Adela Mansilla; Jinghong Ma; Sandra Daack-Hirsch; Brion S Maher; Lisa M Raffensperger; Erilynn T Russo; Alexandre R Vieira; Catherine Dodé; Moosa Mohammadi; Mary L Marazita; Jeffrey C Murray
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-06       Impact factor: 11.205

5.  A genome-wide linkage scan for cleft lip and cleft palate identifies a novel locus on 8p11-23.

Authors:  B M Riley; R E Schultz; M E Cooper; T Goldstein-McHenry; S Daack-Hirsch; K T Lee; E Dragan; A R Vieira; A C Lidral; M L Marazita; J C Murray
Journal:  Am J Med Genet A       Date:  2007-04-15       Impact factor: 2.802

6.  Craniosynostosis.

Authors:  David Johnson; Andrew O M Wilkie
Journal:  Eur J Hum Genet       Date:  2011-01-19       Impact factor: 4.246

7.  Presence of the Apert canonical S252W FGFR2 mutation in a patient without severe syndactyly.

Authors:  M R Passos-Bueno; A Richieri-Costa; A L Sertié; A Kneppers
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

Review 8.  Craniosynostosis: molecular pathways and future pharmacologic therapy.

Authors:  Kshemendra Senarath-Yapa; Michael T Chung; Adrian McArdle; Victor W Wong; Natalina Quarto; Michael T Longaker; Derrick C Wan
Journal:  Organogenesis       Date:  2012-10-01       Impact factor: 2.500

9.  De novo alu-element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome.

Authors:  M Oldridge; E H Zackai; D M McDonald-McGinn; S Iseki; G M Morriss-Kay; S R Twigg; D Johnson; S A Wall; W Jiang; C Theda; E W Jabs; A O Wilkie
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

10.  The ups and downs of mutation frequencies during aging can account for the Apert syndrome paternal age effect.

Authors:  Song-Ro Yoon; Jian Qin; Rivka L Glaser; Ethylin Wang Jabs; Nancy S Wexler; Rebecca Sokol; Norman Arnheim; Peter Calabrese
Journal:  PLoS Genet       Date:  2009-07-10       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.